Issue 62, 2019

Inactivation of myostatin by photo-oxygenation using catalyst-functionalized peptides

Abstract

Inhibition of myostatin is an attractive treatment for muscular dystrophy and other amyotrophic diseases. A myostatin-binding peptide was functionalized by equipped with an on/off switchable photo-oxygenation catalyst. This peptide induces a selective oxygenation of myostatin under near-infrared light, resulting in inactivation of myostatin. This peptide shows several orders of magnitude greater inhibitory effect than the original peptide.

Graphical abstract: Inactivation of myostatin by photo-oxygenation using catalyst-functionalized peptides

Supplementary files

Article information

Article type
Communication
Submitted
07 Jun 2019
Accepted
28 Jun 2019
First published
04 Jul 2019

Chem. Commun., 2019,55, 9108-9111

Inactivation of myostatin by photo-oxygenation using catalyst-functionalized peptides

H. Okamoto, A. Taniguchi, S. Usami, A. Taguchi, K. Takayama and Y. Hayashi, Chem. Commun., 2019, 55, 9108 DOI: 10.1039/C9CC04368C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements